KIORA PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $6.1M | $8.4M |
| FY2016 | — | $-329.4K | $3.6M |
| FY2017 | — | $-1.9M | $7.8M |
| FY2018 | — | $8.9M | $8.0M |
| FY2019 | $0 | $6.6M | $3.8M |
| FY2020 | $278.2K | $9.7M | $1.2M |
| FY2021 | — | $14.6M | $7.9M |
| FY2022 | — | $11.4M | $6.0M |
| FY2023 | — | $6.1M | $2.5M |
| FY2024 | — | $25.8M | $3.8M |